Authors:
Ngui, JS
Chen, Q
Shou, MG
Wang, RW
Stearns, RA
Baillie, TA
Tang, W
Citation: Js. Ngui et al., In vitro stimulation of warfarin metabolism by quinidine: Increases in theformation of 4 '- and 10-hydroxywarfarin, DRUG META D, 29(6), 2001, pp. 877-886
Authors:
Poon, GK
Chen, Q
Teffera, Y
Ngui, JS
Griffin, PR
Braun, MP
Doss, GA
Freeden, C
Stearns, RA
Evans, DC
Baillie, TA
Tang, W
Citation: Gk. Poon et al., Bioactivation of diclofenac via benzoquinone imine intermediates-identification of urinary mercapturic acid derivatives in rats and humans, DRUG META D, 29(12), 2001, pp. 1608-1613
Authors:
Biftu, T
Feng, DD
Liang, GB
Kuo, H
Qian, XX
Naylor, EM
Colandrea, VJ
Candelore, MR
Cascieri, MA
Colwell, LF
Forrest, MJ
Hom, GJ
MacIntyre, DE
Stearns, RA
Strader, CD
Wyvratt, MJ
Fisher, MH
Weber, AE
Citation: T. Biftu et al., Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective beta(3) adrenergic receptor agonist antiobesity agents, BIOORG MED, 10(13), 2000, pp. 1431-1434
Authors:
Tamvakopoulos, CS
Colwell, LF
Barakat, K
Fenyk-Melody, J
Griffin, PR
Nargund, R
Palucki, B
Sebhat, I
Shen, X
Stearns, RA
Citation: Cs. Tamvakopoulos et al., Determination of brain and plasma drug concentrations by liquid chromatography/tandem mass spectrometry, RAP C MASS, 14(19), 2000, pp. 1729-1735
Authors:
Mathvink, RJ
Tolman, JS
Chitty, D
Candelore, MR
Cascieri, MA
Colwell, LF
Deng, LP
Feeney, WP
Forrest, MJ
Hom, GJ
MacIntyre, DE
Miller, RR
Stearns, RA
Tota, L
Wyvratt, MJ
Fisher, MH
Weber, AE
Citation: Rj. Mathvink et al., Discovery of a potent, orally bioavailable beta(3) adrenergic receptor agonist, (R)-N-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide, J MED CHEM, 43(21), 2000, pp. 3832-3836
Authors:
Shih, TL
Candelore, MR
Cascieri, MA
Chiu, SHL
Colwell, LF
Deng, LP
Feeney, WP
Forrest, MJ
Hom, GJ
MacIntyre, DE
Miller, RR
Stearns, RA
Strader, CD
Tota, L
Wyvratt, MJ
Fisher, MH
Weber, AE
Citation: Tl. Shih et al., L-770,644: A potent and selective human beta(3) adrenergic receptor agonist with improved oral bioavailability, BIOORG MED, 9(9), 1999, pp. 1251-1254
Authors:
Parmee, ER
Naylor, EM
Perkins, L
Colandrea, VJ
Ok, HO
Candelore, MR
Cascieri, MA
Deng, LP
Feeney, WP
Forrest, MJ
Hom, GJ
MacIntyre, DE
Miller, RR
Stearns, RA
Strader, CD
Tota, L
Wyvratt, MJ
Fisher, MH
Weber, AE
Citation: Er. Parmee et al., Human beta(3) adrenergic receptor agonists containing cyclic ureidobenzenesulfonamides, BIOORG MED, 9(5), 1999, pp. 749-754
Authors:
Tang, W
Stearns, RA
Wang, RW
Chiu, SHL
Baillie, TA
Citation: W. Tang et al., Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac, CHEM RES T, 12(2), 1999, pp. 192-199
Authors:
Tang, W
Stearns, RA
Bandiera, SM
Zhang, Y
Raab, C
Braun, MP
Dean, DC
Pang, JM
Leung, KH
Doss, GA
Strauss, JR
Kwei, GY
Rushmore, TH
Chiu, SHL
Baillie, TA
Citation: W. Tang et al., Studies on cytochrome P-450-mediated bioactivation of diclofenac in rats and in human hepatocytes: Identification of glutathione conjugated metabolites, DRUG META D, 27(3), 1999, pp. 365-372
Authors:
Tang, W
Stearns, RA
Kwei, GY
Iliff, SA
Miller, RR
Egan, MA
Yu, NX
Dean, DC
Kumar, S
Shou, MG
Lin, JH
Baillie, TA
Citation: W. Tang et al., Interaction of diclofenac and quinidine in monkeys: Stimulation of diclofenac metabolism, J PHARM EXP, 291(3), 1999, pp. 1068-1074